Markets:

Overview

News

Currencies

International

Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Catalent, Inc. Common Stock

< Previous 1 2 3 4 5 Next >

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Catalent, Inc. (CTLT) Investors

March 02, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, and Tesla and Encourages Investors to Contact the Firm

March 01, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Catalent, Inc. (CTLT) Investors

March 01, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Catalent, Inc. (CTLT) Investors of Class Action and to Actively Participate

March 01, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Catalent, Inc. (CTLT) on Behalf of Investors

February 28, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Catalent, Inc. (CTLT) on Behalf of Investors

February 28, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Catalent Publishes Fourth Annual Corporate Responsibility Report Highlighting Achievements While Providing New Record Number of Patient Treatments

February 28, 2023

From Catalent, Inc.

Via Business Wire

CATALENT SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT

February 27, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Catalent, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CTLT

February 27, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

INVESTOR DEADLINE: Catalent, Inc. Investors with Substantial Losses Have Opportunity to Lead the Catalent Class Action Lawsuit – CTLT

February 27, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Catalent, Inc. (CTLT) on Behalf of Investors

February 27, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Catalent, Inc. with Losses of $100,000 to Contact the Firm

February 27, 2023

From The Schall Law Firm

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Catalent, Inc. (CTLT)

February 25, 2023

From Robbins LLP

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Catalent, Inc. with Losses of $100,000 to Contact the Firm

February 24, 2023

From The Schall Law Firm

Via Business Wire

Labaton Sucharow LLP Announces Securities Class Action Lawsuit Filed Against Catalent, Inc. and Certain Executives

February 24, 2023

From Labaton Sucharow LLP

Via Business Wire

The Large Cap Rally Is Largely About These 3 Stocks

February 15, 2023

With a combined weighting of more than 4%, it’s strength in these three tickers that have much to do with the S&P’s 2023 performance.

Via MarketBeat

Topics Economy Stocks

Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary

February 13, 2023

From Catalent, Inc.

Via Business Wire

Catalent, Inc. Reports Second Quarter Fiscal 2023 Results

February 07, 2023

From Catalent, Inc.

Via Business Wire

Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast

January 20, 2023

From Catalent, Inc.

Via Business Wire

Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader

January 17, 2023

From Catalent, Inc.

Via Business Wire

Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate

January 05, 2023

From Catalent, Inc.

Via Business Wire

Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Catalent, Inc.

Via Business Wire

Catalent Announces Changes to its Board of Directors

December 19, 2022

From Catalent, Inc.

Via Business Wire

After a $100 Haircut, is Catalent an Oversold Pharma Play?

November 14, 2022

With the macro backdrop weakening for Catalent’s pharmaceutical and biotech customers, fundamental concerns could outweigh what the charts suggest.

Via MarketBeat

Catalent, Inc. to Present at the Stephens Annual Investment Conference

November 08, 2022

From Catalent, Inc.

Via Business Wire

Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline

November 03, 2022

From Exelixis, Inc.

Via Business Wire

Catalent, Inc. Reports First Quarter Fiscal 2023 Results

November 01, 2022

From Catalent, Inc.

Via Business Wire

Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast

October 17, 2022

From Catalent, Inc.

Via Business Wire

Catalent, Inc. to Present at September Investor Conferences

September 08, 2022

From Catalent, Inc.

Via Business Wire

Catalent, Inc. Reports Fourth Quarter Fiscal 2022 Results

August 29, 2022

From Catalent, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Catalent, Inc. Common Stock (NY:CTLT)

Press Releases about Catalent, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today